【肝癌】預測「TKI」聯合「anti-PD-1」抗體，作為晚期「肝細胞癌(HCC)」二線治療的療效

 【肝癌】預測「酪胺酸激酶抑制劑(TKI)」聯合「anti-PD-1」抗體，作為晚期「肝細胞癌(HCC)」二線治療的療效

▌文章出處

 Scientific Reports

▌原文標題

 Noninvasive imaging-based machine learning algorithm to identify progressive disease in advanced hepatocellular carcinoma receiving second-line systemic therapy

▌文章序號

 3808

｜智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.